Keros Therapeutics Inc : Oppenheimer Initiates Coverage With Outperform Rating; Target Price $102
Keros Therapeutics Inc: Oppenheimer啓動跟蹤,給予超買評級;目標價102美元
Keros Therapeutics Inc : Oppenheimer Initiates Coverage With Outperform Rating; Target Price $102
Keros Therapeutics Inc: Oppenheimer啓動跟蹤,給予超買評級;目標價102美元
譯文內容由第三人軟體翻譯。